Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 16 2020 - 7:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or
15d-16
of the Securities Exchange Act of 1934
Date of Report: November 16, 2020
Commission File Number: 001-39307
Legend Biotech Corporation
(Exact Name of Registrant as Specified in its Charter)
2101
Cottontail Lane
Somerset, New Jersey 08873
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Earnings Release
On November 16, 2020, Legend Biotech Corporation (the Company) issued a press release regarding its unaudited financial results for the three
and nine months ended September 30, 2020 and recent business highlights, which is attached to this Form 6-K as Exhibit 99.1.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
LEGEND BIOTECH CORPORATION
(Registrant)
|
|
|
|
|
November 16, 2020
|
|
|
|
By:
|
|
/s/ Ying Huang
|
|
|
|
|
|
|
Ying Huang, Ph.D.
|
|
|
|
|
|
|
Chief Executive Officer and Chief Financial Officer
|
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Oct 2023 to Oct 2024